Mitigative and anti-inflammatory effects of Trichostatin A against radiation induced gastrointestinal toxicity and gut microbiota alteration in mice.

PURPOSE Radiation-induced gastrointestinal injury (RIGI) is a serious side effect of abdominal and pelvic radiotherapy, which often limits the treatment of gastrointestinal and gynaecological cancers. RIGI is also observed during accidental radiological or nuclear scenarios with no approved agents available till date to prevent or mitigate RIGI in humans. Trichostatin A (TSA), an epigenetic modulator, has been currently in clinical trials for cancer treatment and is also well known for its antibiotic and antifungal properties. METHODS In this study, partial body (abdominal) irradiation mice model has been used to investigate the mitigative effect of TSA against gastrointestinal toxicity caused by gamma radiation. Mice were checked for alterations in mean body weight, diarrhea incidence, disease activity index and survival against radiation. Structural abnormalities in intestine and changes in microbiota composition were studied by histopathology and 16S rRNA sequencing of fecal samples respectively. Immunoblotting and biochemical assays were performed to check protein nitrosylation, expression of inflammatory mediators, infiltration of inflammatory cells and changes in pro-inflammatory cytokines. RESULTS TSA administration to C57Bl/6 mice improved radiation induced mean body weight loss, maintained better health score, reduced disease activity index and promoted survival. The 16S rRNA sequencing of fecal DNA demonstrated that TSA influenced the fecal microbiota dynamics with significant alterations in the Firmicutes/Bacteriodetes ratio. TSA effectively mitigated intestinal injury, down-regulated NF-κB, Cox-2, iNOS, inhibited PGE2 and protein nitrosylation levels in irradiated intestine. The upregulation of NLRP3-inflammasome complex and infiltrations of inflammatory cells in the inflamed intestine were also prevented by TSA. Subsequently, the myeloperoxidase activity in intestine alongwith serum IL-18 levels was found reduced. CONCLUSION These findings provide evidence that TSA inhibits inflammatory mediators, alleviates gut dysbiosis, and promotes structural restoration of the irradiated intestine. TSA, therefore, can be considered as a potential agent for mitigation of RIGI in humans.

[1]  Wei Chen,et al.  Potential role of gut microbiota and its metabolites in radiation-induced intestinal damage. , 2022, Ecotoxicology and environmental safety.

[2]  Nan Ding,et al.  Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury , 2021, Frontiers in Cellular and Infection Microbiology.

[3]  M. Satyamitra,et al.  Acute Radiation Syndrome and the Microbiome: Impact and Review , 2021, Frontiers in Pharmacology.

[4]  V. Singh,et al.  Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure , 2021, Frontiers in Pharmacology.

[5]  A. Dutta,et al.  Quercetin-3-rutinoside protects against gamma radiation inflicted hematopoietic dysfunction by regulating oxidative, inflammatory, and apoptotic mediators in mouse spleen and bone marrow , 2021, Free radical research.

[6]  M. Nitert,et al.  The Gut Microbiota and Inflammation: An Overview , 2020, International journal of environmental research and public health.

[7]  N. Gupta,et al.  Gut microbiota response to ionizing radiation and its modulation by HDAC inhibitor TSA , 2020, International journal of radiation biology.

[8]  Saijun Fan,et al.  Baicalein ameliorates ionizing radiation-induced injuries by rebalancing gut microbiota and inhibiting apoptosis. , 2020, Life sciences.

[9]  Wei-Dong Chen,et al.  The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages , 2020, Frontiers in Microbiology.

[10]  Zhenguo Zhao,et al.  Antibiotic Alleviates Radiation-Induced Intestinal Injury by Remodeling Microbiota, Reducing Inflammation, and Inhibiting Fibrosis , 2020, ACS omega.

[11]  Chao Sun,et al.  Phycocyanin Ameliorates Radiation-Induced Acute Intestinal Toxicity by Regulating the Effect of the Gut Microbiota on the TLR4/Myd88/NF-κB Pathway. , 2019, JPEN. Journal of parenteral and enteral nutrition.

[12]  M. Eghbali,et al.  Radiation mitigation of the intestinal acute radiation injury in mice by 1‐[(4‐nitrophenyl)sulfonyl]‐4‐phenylpiperazine , 2019, Stem cells translational medicine.

[13]  O. Pabst,et al.  Inflammation triggers immediate rather than progressive changes in monocyte differentiation in the small intestine , 2019, Nature Communications.

[14]  Yuan He,et al.  The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation , 2019, International journal of molecular sciences.

[15]  P. Rana,et al.  Trichostatin A, an epigenetic modifier, mitigates radiation-induced androphysiological anomalies and metabolite changes in mice as evident from NMR-based metabolomics , 2018, International journal of radiation biology.

[16]  T. Spector,et al.  Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.

[17]  M. Gupta,et al.  Podophyllotoxin and rutin in combination prevents oxidative stress mediated cell death and advances revival of mice gastrointestine following lethal radiation injury , 2018, Free radical research.

[18]  Jie-shou Li,et al.  Soluble Dietary Fiber Ameliorates Radiation-Induced Intestinal Epithelial-to-Mesenchymal Transition and Fibrosis , 2017, JPEN. Journal of parenteral and enteral nutrition.

[19]  J. Kiang,et al.  Hemorrhage enhances cytokine, complement component 3, and caspase-3, and regulates microRNAs associated with intestinal damage after whole-body gamma-irradiation in combined injury , 2017, PloS one.

[20]  Zhanju Liu,et al.  Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease , 2017, Journal of digestive diseases.

[21]  H. Sokol,et al.  The microbiota: an underestimated actor in radiation-induced lesions? , 2017, Gut.

[22]  Junling Zhang,et al.  Faecal microbiota transplantation protects against radiation‐induced toxicity , 2017, EMBO molecular medicine.

[23]  W. Tomé,et al.  A Model for Precise and Uniform Pelvic- and Limb-Sparing Abdominal Irradiation to Study the Radiation-Induced Gastrointestinal Syndrome in Mice Using Small Animal Irradiation Systems , 2017, Dose-response : a publication of International Hormesis Society.

[24]  A. Margolles,et al.  Effect of a Ropy Exopolysaccharide-Producing Bifidobacterium animalis subsp. lactis Strain Orally Administered on DSS-Induced Colitis Mice Model , 2016, Front. Microbiol..

[25]  S. Minucci,et al.  Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia , 2016, British Journal of Cancer.

[26]  N. Haboubi,et al.  Pelvic radiation therapy: Between delight and disaster. , 2015, World journal of gastrointestinal surgery.

[27]  O. Desouky,et al.  Targeted and non-targeted effects of ionizing radiation , 2015 .

[28]  M. Hauer-Jensen,et al.  Radiation enteropathy—pathogenesis, treatment and prevention , 2014, Nature Reviews Gastroenterology &Hepatology.

[29]  E. Wright,et al.  Responses to ionizing radiation mediated by inflammatory mechanisms , 2014, The Journal of pathology.

[30]  F. Milliat,et al.  Inflammation and Immunity in Radiation Damage to the Gut Mucosa , 2013, BioMed research international.

[31]  F. Sullivan,et al.  Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. , 2013, World journal of gastroenterology.

[32]  Alexandra C Miller,et al.  Radioprotection by the histone deacetylase inhibitor phenylbutyrate , 2011, Radiation and environmental biophysics.

[33]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[34]  T. Lawrence.  The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.

[35]  V. Gadaleanu,et al.  Local radiotherapy of exposed murine small bowel: apoptosis and inflammation. , 2008, BMC surgery.

[36]  P. Marks,et al.  Histone deacetylase inhibitors: molecular mechanisms of action , 2007, Oncogene.

[37]  J. Panés,et al.  Radiation-induced intestinal inflammation. , 2007, World journal of gastroenterology.

[38]  J. Gordon,et al.  Microbial regulation of intestinal radiosensitivity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Lesley J. Murray,et al.  Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. , 2004, Cytotherapy.

[40]  S. Kyrylenko,et al.  Regulation of microglial inflammatory response by histone deacetylase inhibitors , 2003, Journal of neurochemistry.

[41]  C. Parkos,et al.  Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair. , 1997, Gastroenterology.

[42]  H. Withers,et al.  Comparison of the gastrointestinal syndrome after total-body or total-abdominal irradiation. , 1989, Radiation research.

[43]  W. Stenson,et al.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: Assessment of inflammation in rat and hamster models , 1984 .

[44]  M. Glick,et al.  A simplified, colorimetric micromethod for xylose in serum or urine, with phloroglucinol. , 1979, Clinical chemistry.

[45]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.